Cargando…

Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China

INTRODUCTION: The aim of this study was to evaluate the cost-effectiveness of rivaroxaban and apixaban versus enoxaparin for the universal prophylaxis of venous thromboembolism (VTE) and associated long-term complications in Chinese patients after total hip replacement (THR). METHODS: A decision mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Xiaoyu, Gu, Xiaohua, Xu, Zhenxing, Lin, Houweng, Wu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331091/ https://www.ncbi.nlm.nih.gov/pubmed/28000167 http://dx.doi.org/10.1007/s12325-016-0460-0

Ejemplares similares

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service
por: Dawoud, Dalia M., et al.
Publicado: (2018)

Venous Thromboembolism in Total Hip and Total Knee Arthroplasty
por: Simon, Samantha J., et al.
Publicado: (2023)

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement
por: Dranitsaris, George, et al.
Publicado: (2011)

Intermittent Pneumatic Compression for the Prevention of Venous Thromboembolism after Total Hip Arthroplasty
por: Kwak, Hong Suk, et al.
Publicado: (2017)

Thromboprophylaxis for venous thromboembolism prevention in hip fracture patients
Publicado: (2017)

Efficacy and Safety of Enoxaparin versus New Oral Anticoagulants to Prevent Venous Thromboembolism after Total Hip Replacement: A Systematic Review and Meta-Analysis
por: Alfarhan, Mohammed Farhan A
Publicado: (2022)

Cost-Effectiveness Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Knee Replacement Surgery in Iran
por: Abutorabi, Ali, et al.
Publicado: (2023)

Preventing Venous Thromboembolism with Use of Intermittent Pneumatic Compression after Total Hip Arthroplasty in Korean Patients
por: Jo, Woo-Lam, et al.
Publicado: (2016)

Venous thromboembolism after total knee and hip arthroplasty: A retrospective study
por: Almegren, Mosaad O., et al.
Publicado: (2018)

The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty
por: Russell, Robert D., et al.
Publicado: (2013)

Current status survey of the extramural hospital management of venous thromboembolism after total hip and knee arthroplasty in China
por: Tong, Kai, et al.
Publicado: (2021)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
por: Levitan, Bennett, et al.
Publicado: (2014)

Nursing Care and Barriers for Prevention of Venous Thromboembolism in Total Knee and Hip Arthroplasty Patients: A Qualitative Study
por: Al-Mugheed, Khalid, et al.
Publicado: (2023)

Review of the cost of venous thromboembolism
por: Fernandez, Maria M, et al.
Publicado: (2015)

Fatal pulmonary thromboembolism during total hip replacement under spinal anesthesia
por: Cho, Yong-Hyun, et al.
Publicado: (2013)

Strategies for Diagnosis and Prevention of Venous Thromboembolism during Pregnancy
por: Bagaria, Shalini Jain, et al.
Publicado: (2011)

The effects of information platform-based nursing on preventing venous thromboembolism in patients with hip fractures
por: Gao, Yuan, et al.
Publicado: (2022)

The Risk of Venous Thromboembolism is Not Equal for all Patients Who Undergo Total Joint Replacement
por: Tafur, Alfonso, et al.
Publicado: (2019)

Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data
por: Kwong, Louis M
Publicado: (2011)

Comparison of Venous Thromboembolism after Total Hip Arthroplasty between Ankylosing Spondylitis and Osteoarthritis
por: Shi, Dongquan, et al.
Publicado: (2014)

Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification
por: Vaz, Kenneth M., et al.
Publicado: (2020)

Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
por: Fuji, Takeshi, et al.
Publicado: (2015)

Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review
por: Zhang, Yuan, et al.
Publicado: (2022)

Recent Updates of the Diagnosis and Prevention of Venous Thromboembolism in Patients with a Hip Fracture
por: Shin, Won Chul, et al.
Publicado: (2017)

Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis
por: Lu, Xin, et al.
Publicado: (2018)

Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years
por: Zhang, Zi-hao, et al.
Publicado: (2015)

Prevention of Venous Thromboembolism in Patients Undergoing Hip Fracture Surgery: A Survey of the Korean Hip Society
por: Kim, Chang Hyun, et al.
Publicado: (2023)

Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis
por: Hu, Bangsheng, et al.
Publicado: (2021)

Prevention and treatment of venous thromboembolism
por: Casadei, Barbara, et al.
Publicado: (2020)

Epidemiology and prevention of venous thromboembolism
por: Lutsey, Pamela L., et al.
Publicado: (2022)

Cost‐minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D‐dimer for exclusion of venous thromboembolism
por: Verma, Karan, et al.
Publicado: (2017)

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 3. Pharmacological venous thromboembolism prophylaxis
por: Thiengwittayaporn, Satit, et al.
Publicado: (2021)

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis
por: Amarase, Chavarin, et al.
Publicado: (2021)

Risk of venous thromboembolism after total hip and knee replacement in older adults with comorbidity and co-occurring comorbidities in the Nationwide Inpatient Sample (2003-2006)
por: Kapoor, Alok, et al.
Publicado: (2010)

Venous thromboembolism rates after hip and knee arthroplasty and hip fractures
por: Mula, Viswanath, et al.
Publicado: (2020)

Prevention of early complications following total hip replacement
por: Fontalis, Andreas, et al.
Publicado: (2021)

Fondaparınux Versus Nadroparın for Preventıon of Venous Thromboembolısm After Electıve Hıp and Knee Arthroplasty()
por: Argun, Mahmut, et al.
Publicado: (2013)

Incidence of Symptomatic Venous Thromboembolism in Patients with Hemophilia Undergoing Hip and Knee Joint Replacement without Chemoprophylaxis: A Retrospective Study
por: Peng, Hui‐ming, et al.
Publicado: (2019)

Venous thromboembolism prevention protocol for adapting prophylaxis recommendations to the potential risk post total knee replacement: a randomized controlled trial
por: Alameri, Mariam A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dopa6bcl4upg91m223bov6q40t